UGCG and myeloid leukemia: Inhibition of ceramide formation by increasing GCS results in development of drug resistance in breast cancer cells [127], while inhibition of GCS reverses drug resistance through endogenous ceramide accumulation as seen in myeloid leukemia cells [128].